-
-
-
-
-
-
-
TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s KVA12123 Novel anti-VISTA Checkpoint Inhibitor
-
-
-
-
-
-
-
Kineta (KA) Announces Restructuring and Exploration of Strategic Alternatives
-
-
-
-
-
-
1,157,963 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

